Microchimerism and HLA-compatible relationships of pregnancy in scleroderma

Lancet

Volumn 351, Issue 9102, 1998, Pages 559-562

  Nelson, J Lee ^a,b   Furst, Daniel E ^c   Maloney, Sean ^a   Gooley, Ted ^a   Evans, Paul C ^a   Smith, Anajane ^a   Bean, Michael A ^d   Ober, Carole ^e   Bianchi, Diana W ^f  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; HLA ANTIGEN CLASS 2;

ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; FEMALE; FETUS CELL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN EXPERIMENT; INCIDENCE; MICROCHIMERISM; NORMAL HUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; SCLERODERMA; SEX DIFFERENCE; STEM CELL; Y CHROMOSOME;

EID: 16744367907     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)08357-8     Document Type: Article

References (27)

1. 1 Bianchi DW. Prenatal diagnosis by analysis of fetal cells in maternal blood. J Pediatr 1995; 127: 847-56.
2. 2 Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996; 93: 705-08.
3. 3 Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB. Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med 1977; 87: 707-09.
4. 4 Furst DE, Clements PJ, Graze P, Gale R, Roberts N. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: a model for scleroderma? Arthritis Rheum 1979; 22: 904-10.
5. 5 Silman AJ, Hochberg MC. Scleroderma. In: Silman AJ, Hochberg MC, eds. Epidemiology of the rheumatic diseases. Oxford: Oxford University Press, 1993: 192-219.
6. 6 Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996; 39: 191-94.
7. 7 Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and ancuploid pregnancies. Am J Hum Genet 1997; 61: 822-29.
8. 8 McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion-associated graft versus-host disease. Transfus Med Rev 1993; 7: 37-41.
9. 9 Masi A, Rodnan G, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
10. 10 Lee TH, Paglieroni T, Holland PV, Busch MP. Frequent engraftment of donor stem cells in multiply transfused patients. J Allergy Clin Immunol 1997; 99: 468 (abstr).
11. 11 De Moor G, De Bock G, Noens L, De Bic S. A new case of human chimerism detected after pregnancy: 46,XY karyotype in the lymphocytes of a woman. Acta Clin Belg 1988; 43: 231-35.
12. 12 Lucotte G, David F, Mariottl M. Nucleotide sequence of p49a, a genomic Y-specific probe with potential utilization in sex determination. Mol Cell Probes 1991; 5: 359-63.
13. 13 Mickleson E, Smith A, McKinney S, Anderson G, Hansen JA. A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA. Tissue Antigens 1993; 41: 86-93.
14. 14 Smith AG, Nelson JL, Regen L, et al. Six new DR52-associated DRB1 alleles, three of DR8, two of DR11, and one of DR6, reflect a variety of mechanisms which generate polymorphism in the MHC. Tissue Antigens 1996; 48: 118-26.
15. 15 Nelson JL, Hughes KA, Smith AG, Nisperos BB, Brabchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329: 466-71.
16. 16 Bodmer JG, Marsh SGE, Ekkehard DA et al. Nomenclature for factors of the HLA system 1996. Tissue Antigens 1997; 49: 297-321.
17. 17 Claman HN, ed. The immunology of human pregnancy. Totowa, New Jersey: Humana Press, 1993.
18. 18 Tafuri A, Alferink J, Möller P, Hämmerling G, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270: 630-33.
19. 19 Englert H, Brennan P, McNeil D, Black C, Silman AJ. Reproductive function prior to disease onset in women with scleroderma. J Rheumatol 1992; 19: 1575-79.
20. 20 Thomas MR, Williamson R, Craft I, Yazdani N, Rodeck CH. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994; 343: 413-14.
21. 21 Lo YMD, Lo ESF, Watson N, et al. Two-way traffic between mother and fetus: biological and clinical implications. Blood 1996; 88: 4390-95.
22. 22 Hall JM, Lingenfelter P, Adams SL, Lasser D, Hansen JA, Bean MA. Detection of maternal cells in umbilical cord blood using fluoresence in situ hybridization. Blood 1995; 86: 2829-32.
23. 23 Piotrowski P, Croy BA. Maternal cells are widely distributed in murine fetuses in utero. Biol Reprod 1996; 54: 1103-10.
24. 24 Pollack MS, Kirpatrick D, Kapoor N, Dupont B, O'Reilly RJ. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982; 307: 662-66.
25. 25 Hutchinson DL, Turner JH, Schlesinger ER. Persistence of donor cells in neonates after fetal and exchange transfusion. Am J Obstet Gynecol 1971; 109: 281-84.
26. 26 Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997; 158: 40-47.
27. 27 Fink PJ, Shimonkevitz RP, Bevan MJ. Veto cells. Annu Rev Immunol 1988; 6: 115-37.